Loading the company…
Loading the company…
㈜바이오스타줄기세포기술연구원
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2021. Industry: Holding & Financial Services. Revenue for 2025 was ₩37.4bn. It has 95 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Disclaimer of opinion”.
Loading…
Latest filing 2024-07-05 · newest first
본 발명은 원지 추출물에 산도조절제를 혼합하는 단계를 포함하는 원지 추출물의 아린 맛을 개선시키는 방법에 관한 것으로, 본 발명에 따르면, 종래 원지 특유의 아린 맛으로 인하여 음용이 어려웠던 원지 추출물의 아린 맛을 제거하여, 기억력 개선 효과를 갖는 원지 추출물을 소비자가 보다 쉽게 음용할 수 있는 효과가 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 45.2 | 37.4 |
| Cost of sales | 38.7 | 17.6 |
| Gross profit (loss) | 6.5 | 19.8 |
| Selling, general and administrative expenses | 24.3 | 30.9 |
| Operating income (loss) | 17.8 | 11.0 |
| Non-operating income | 2.5 | 2.5 |
| Other gains | 0.9 | 0.3 |
| Finance income | 1.0 | 0.7 |
| Other | 0.6 | 1.4 |
| Non-operating expenses | 4.1 | 5.8 |
| Other losses | 0.3 | 0.1 |
| Finance costs | 0.1 | 0.2 |
| Other | 3.7 | 5.5 |
| Profit (loss) before tax | 19.4 | 14.4 |
| Income tax expense | 0.1 | (0.1) |
| Net income (loss) | 19.4 | 14.3 |
Revenue ₩37.4bn, down 17.3% YoY.
Operating margin 29.4% (prior 39.3%).
Net income ₩14.3bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.